HSBC Holdings’s Longevity Health Holdings, Inc. Common Stock XAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-21,200
Closed -$6.56M 2881
2023
Q2
$6.56M Hold
21,200
0.01% 958
2023
Q1
$6.47M Hold
21,200
0.01% 1008
2022
Q4
$6.3M Hold
21,200
0.01% 1158
2022
Q3
$6.17M Hold
21,200
0.01% 1095
2022
Q2
$6.16M Buy
+21,200
New +$6.16M 0.01% 1114

Other funds holding XAGE

HSBC Holdings's XAGE Position: Q3 2023 in Review

HSBC Holdings sold out of Longevity Health Holdings, Inc. Common Stock (XAGE) in Q3 2023, closing a stake of 21,200 shares — an estimated $6.56M sold.

HSBC Holdings first reported a position in XAGE in Q2 2022 and held it in 5 quarters. The position peaked at $6.56M in Q2 2023. 14 funds tracked by Wall St. Rank hold XAGE as of Q3 2023.

  • HSBC Holdings reported no remaining Longevity Health Holdings, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • HSBC Holdings sold 21,200 Longevity Health Holdings, Inc. Common Stock shares in Q3 2023, an estimated $6.56M.
  • HSBC Holdings first reported a position in Longevity Health Holdings, Inc. Common Stock in Q2 2022 and held it in 5 quarters.
  • HSBC Holdings's Longevity Health Holdings, Inc. Common Stock position peaked at $6.56M in Q2 2023.
  • 14 funds tracked by Wall St. Rank held Longevity Health Holdings, Inc. Common Stock as of Q3 2023.

Based on HSBC Holdings's 13F filing for Q3 2023, filed 13 Nov 2023.